Point of Care Molecular Diagnostics Market Growth Analysis, Demand, Trends and Developments Forecast to 2028

The global Point of Care Molecular Diagnostics Market was valued at USD 883.5 Million in 2020 and is expected to reach USD 2,530.4 Million by the year 2028, at a CAGR of 13.9%. Molecular point-of-care (POC) diagnostics have been used to improve the sensitivity and specificity of existing near-patient to perform rapid tests and expand the diagnostic capabilities at points of care such as in-hospital critical care units, physician offices, outpatient clinics. POC molecular testing enables physicians to enhance the standard of living by uniting in better diagnosis with treatment. Genetic sequencing is a major technology used in molecular diagnostics at POC. It uses mutation-specific targeted analysis sequencing, and further investigation for the diagnosis of ‘single-gene’ ailments and next-generation sequencing will enhance the simultaneous multi-gene examination, which is used to sequence exomes for direct clinical testing. This technological development is forecasted to fuel molecular diagnosis.

It is segmented into key regions around the world based on growth rate, share, size, trends, current and emerging factors, production and consumption ratios, industrial chain analysis, demand and supply, import and export, revenue contribution, and key player presence across the globe. To gain a better understanding of the regional spread and progress of the Point of Care Molecular Diagnostics Market, the report provides a country-by-country analysis of the market.

Request a sample Report of Point of Care Molecular Diagnostics Market @https://www.reportsanddata.com/download-free-sample/2535

Market Overview:

A growing number of patients are benefiting from cell and gene therapies; previously incurable diseases are finding a cure. Pharmaceutical and healthcare sectors are changing rapidly. With the advent of artificial intelligence (AI) and machine-learning technologies, expectations are rising for more inventive, faster, and less expensive therapeutic development. A data-driven approach could be beneficial to the manufacturing, supply chain, and healthcare ecosystem at large. As a result of increased technology use and data sharing, as well as increased willingness to use prescription and treatment tools, attitudes and behaviors of consumers are changing. Over the next few years, such factors are expected to drive the growth of the pharmaceutical and healthcare markets.

Browse Full Report Description with Research Methodology, Table of Content, and Infographics @https://www.reportsanddata.com/request-latest-insight/2535

Companies considered and profiled in this market study

Abbott Laboratories (US), Biomerieux (France), Danaher (US), Roche diagnostics (Switzerland), Meridian biosciences (US), Quidel (US), Johnson Johnson (US), Cepheid(US), Bio-Rad Laboratories(US), Becton(US), Dickinson and Company(US), Alere, Inc(US), Bayer healthcare pharmaceuticals are the key market players of point of care molecular diagnostics market.

Segments covered in the report

This report forecasts revenue growth at a global, regional country level, and provides an analysis of the market trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Reports and Data have segmented the Point of Care Molecular Diagnostics market on the basis of product and service, technology, application, end use and region:

Product and Service Outlook (Revenue in Million USD; 2020–2028)

Assays Kits
Instruments/Analyzers
Services Software

Technology Outlook (Revenue in Million USD; 2020–2028)

Polymerase Chain Reaction (PCR)
Genetic Sequencing (DNA based sequencing)
Hybridization-based (In-Situ Hybridization)
Microarray-based (Chips and Microarrays)
Real Time Polymerase Chain Reaction
Mass Spectrometry
Isothermal Amplification
Others

Application Outlook (Revenue in Million USD; 2020–2028

Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Sexually transmitted diseases
Health care associated infection
Others

End Use Outlook (Revenue in Million USD; 2020–2028

Hospitals
Clinics
Homecare
Assisted Living Healthcare Facilities
Decentralized Labs
Others

Regional Outlook (Revenue in Million USD; 2020–2028)

North America

U.S
Canada

Europe

Germany
France
U.K
Spain
Italy
Rest of the Europe

Asia Pacific

China
India
Japan
Rest of Asia-Pacific

Middle East Africa
Latin America

Brazil

Press Release @https://www.reportsanddata.com/press-release/global-point-of-care-molecular-diagnostics-market

Major Points covered in this report are as below:

In this report, market development trends and marketing channels in the Point of Care Molecular Diagnostics Market industry are analyzed, feasibility of new investment projects is evaluated, and overall conclusions are presented.

This report provides key industry statistics through tables and figures, serving as an invaluable source of information and advice for companies and individuals involved in this sector.

Additionally, this report analyzes development policies and plans, manufacturing processes, and cost structures, as well as import/export consumption figures, supply and demand figures, costs, prices, revenues, and gross margins.

For companies and individuals interested in the Point of Care Molecular Diagnostics Market industry, the Point of Care Molecular Diagnostics Market report provides information on the current market status of the Point of Care Molecular Diagnostics Market manufacturers and provides valuable guidance and direction.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @https://www.reportsanddata.com/request-customization-form/2535

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs